State of Wisconsin Investment Board
RCUS icon

State of Wisconsin Investment Board’s Arcus Biosciences RCUS Stock Holding History

State of Wisconsin Investment Board’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
82,399
+23,202
+39% +$573K 0.01% 1382
2026
Q1 		$1.28M Buy
59,197
+362
+0.6% +$7.82K ﹤0.01% 1587
2025
Q4 		$1.4M Buy
58,835
+28,117
+92% +$574K ﹤0.01% 1537
2025
Q3 		$418K Hold
30,718
– – ﹤0.01% 1970
2025
Q2 		$250K Buy
30,718
+878
+3% +$7.5K ﹤0.01% 2133
2025
Q1 		$234K Sell
29,840
-16,970
-36% -$197K ﹤0.01% 2063
2024
Q4 		$697K Buy
46,810
+16,961
+57% +$277K ﹤0.01% 1664
2024
Q3 		$456K Hold
29,849
– – ﹤0.01% 1913
2024
Q2 		$455K Sell
29,849
-1,596
-5% -$25.8K ﹤0.01% 1869
2024
Q1 		$594K Sell
31,445
-4,052
-11% -$70.1K ﹤0.01% 1652
2023
Q4 		$678K Sell
35,497
-8,346
-19% -$133K ﹤0.01% 1540
2023
Q3 		$787K Buy
43,843
+6,837
+18% +$137K ﹤0.01% 1487
2023
Q2 		$752K Sell
37,006
-2,013
-5% -$38.3K ﹤0.01% 1585
2023
Q1 		$712K Sell
39,019
-4,379
-10% -$83.7K ﹤0.01% 1660
2022
Q4 		$897K Sell
43,398
-332
-0.8% -$9.14K ﹤0.01% 1549
2022
Q3 		$1.14M Buy
43,730
+1,345
+3% +$35.6K ﹤0.01% 1491
2022
Q2 		$1.07M Sell
42,385
-14,315
-25% -$351K ﹤0.01% 1602
2022
Q1 		$1.79M Sell
56,700
-8,000
-12% -$268K ﹤0.01% 1530
2021
Q4 		$2.62M Buy
64,700
+8,000
+14% +$310K 0.01% 1203
2021
Q3 		$1.98M Hold
56,700
– – ﹤0.01% 1288
2021
Q2 		$1.56M Sell
56,700
-11,400
-17% -$326K ﹤0.01% 1340
2021
Q1 		$1.91M Sell
68,100
-177,200
-72% -$6.17M ﹤0.01% 1244
2020
Q4 		$6.37M Sell
245,300
-2,900
-1% -$70.2K 0.01% 895
2020
Q3 		$4.25M Buy
248,200
+194,500
+362% +$4.35M 0.01% 984
2020
Q2 		$1.33M Buy
53,700
+3,600
+7% +$97.2K ﹤0.01% 1189
2020
Q1 		$695K Buy
50,100
+2,800
+6% +$34.8K ﹤0.01% 1269
2019
Q4 		$478K Hold
47,300
– – ﹤0.01% 1461
2019
Q3 		$430K Buy
47,300
+4,000
+9% +$32.1K ﹤0.01% 1376
2019
Q2 		$344K Buy
43,300
+1,000
+2% +$10K ﹤0.01% 1414
2019
Q1 		$528K Buy
+42,300
New +$459K ﹤0.01% 1333

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State of Wisconsin Investment Board's RCUS Position: Q2 2026 in Review

State of Wisconsin Investment Board increased its Arcus Biosciences (RCUS) stake by 39% in Q2 2026, buying an estimated $573K and bringing the position to 82,399 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #1382.

State of Wisconsin Investment Board first reported a position in RCUS in Q1 2019 and has held it in 30 quarters since. The position peaked at $6.37M in Q4 2020. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • State of Wisconsin Investment Board held 82,399 shares of Arcus Biosciences worth $2.54M as of Q2 2026.
  • State of Wisconsin Investment Board bought 23,202 Arcus Biosciences shares in Q2 2026, an estimated $573K.
  • Arcus Biosciences made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #1382 holding.
  • State of Wisconsin Investment Board first reported a position in Arcus Biosciences in Q1 2019 and has held it in 30 quarters since.
  • State of Wisconsin Investment Board's Arcus Biosciences position peaked at $6.37M in Q4 2020.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.